ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,204, issued on June 24, was assigned to Texas Tech University System (Lubbock, Texas).
"Substituted bisphenylalkylurea compounds and methods of treating breast cancer" was invented by Nadezhda German (Amarillo, Texas), Ruwein Zhang (Sugar Land, Texas), Wei Wang (Sugar Land, Texas), Constantinos Mikelis (Amarillo, Texas) and Luca Cucullo (Amarillo, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a composition and method for a therapeutic treatment that is able to combat triple negative breast cancers (TNBCs). The class of urea compounds acts by blocking at inhibiting the mTOR signaling pathway, which, as a central regulator of mamma...